CN106011216B - Method for producing 1,5-pentanediamine by microorganism combined culture - Google Patents
Method for producing 1,5-pentanediamine by microorganism combined culture Download PDFInfo
- Publication number
- CN106011216B CN106011216B CN201610609543.2A CN201610609543A CN106011216B CN 106011216 B CN106011216 B CN 106011216B CN 201610609543 A CN201610609543 A CN 201610609543A CN 106011216 B CN106011216 B CN 106011216B
- Authority
- CN
- China
- Prior art keywords
- culture
- fermentation
- solution
- producing
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 title claims abstract description 64
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 19
- 244000005700 microbiome Species 0.000 title claims abstract description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 93
- 238000000855 fermentation Methods 0.000 claims abstract description 77
- 230000004151 fermentation Effects 0.000 claims abstract description 77
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 42
- 239000008103 glucose Substances 0.000 claims abstract description 42
- 239000001963 growth medium Substances 0.000 claims abstract description 33
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000002609 medium Substances 0.000 claims abstract description 24
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000004472 Lysine Substances 0.000 claims abstract description 22
- 241000894006 Bacteria Species 0.000 claims abstract description 21
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 20
- 239000008101 lactose Substances 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 17
- 239000001384 succinic acid Substances 0.000 claims abstract description 12
- 238000011218 seed culture Methods 0.000 claims abstract description 11
- 230000001954 sterilising effect Effects 0.000 claims abstract description 11
- 230000001939 inductive effect Effects 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000011081 inoculation Methods 0.000 claims description 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 238000003501 co-culture Methods 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229960000723 ampicillin Drugs 0.000 claims description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 3
- 229960005091 chloramphenicol Drugs 0.000 claims description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims description 3
- 239000012531 culture fluid Substances 0.000 claims description 3
- 235000013619 trace mineral Nutrition 0.000 claims description 3
- 239000011573 trace mineral Substances 0.000 claims description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 2
- 230000001133 acceleration Effects 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 229910052603 melanterite Inorganic materials 0.000 claims description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 2
- 229960003495 thiamine Drugs 0.000 claims description 2
- 235000019157 thiamine Nutrition 0.000 claims description 2
- 239000011721 thiamine Substances 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 53
- 230000001276 controlling effect Effects 0.000 description 10
- 229960005137 succinic acid Drugs 0.000 description 8
- 239000004952 Polyamide Substances 0.000 description 7
- 229920002647 polyamide Polymers 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 108010048581 Lysine decarboxylase Proteins 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 5
- 241001052560 Thallis Species 0.000 description 5
- 235000011114 ammonium hydroxide Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001502 supplementing effect Effects 0.000 description 5
- 239000006052 feed supplement Substances 0.000 description 4
- KJOMYNHMBRNCNY-UHFFFAOYSA-N pentane-1,1-diamine Chemical compound CCCCC(N)N KJOMYNHMBRNCNY-UHFFFAOYSA-N 0.000 description 4
- 108090000489 Carboxy-Lyases Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000009423 ventilation Methods 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 230000036983 biotransformation Effects 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 229910019626 (NH4)6Mo7O24 Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- KURKFQKYOHAHGX-UHFFFAOYSA-N C(CCCC)(N)N.C(CCC(=O)O)(=O)O Chemical compound C(CCCC)(N)N.C(CCC(=O)O)(=O)O KURKFQKYOHAHGX-UHFFFAOYSA-N 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 229910052927 chalcanthite Inorganic materials 0.000 description 1
- 239000013064 chemical raw material Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- VMNZBBHWHOMWAQ-UHFFFAOYSA-N pentane-1,5-diamine Chemical compound NCCCCCN.NCCCCCN VMNZBBHWHOMWAQ-UHFFFAOYSA-N 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000029219 regulation of pH Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a method for producing 1,5-pentanediamine by microorganism combined culture. The method comprises the following steps: a seed preparation culture medium, a fermentation culture medium, a glucose feeding culture solution, a glycerol feeding culture solution, a lactose inducing solution and a lysine solution; sterilizing a fermentation tank, the culture medium in the step 1 and a triangular flask, wherein glucose in the fermentation culture medium in the step 1 is sterilized independently; inoculating a seed culture medium into a triangular flask, and inoculating succinic acid-producing bacteria and lysine-producing decarboxylase bacteria respectively to be cultured to be used as fermentation strains; introducing sterile air or pure O into a fermentation tank filled with a fermentation medium2Inoculating succinic acid-producing bacteria and lysine-producing decarboxylase bacteria as starting strains, adding glucose supplemented culture solution, glycerol supplemented culture solution and lactose inducing solution, and controlling the specific growth rate of the bacteria for fermentation; and in the anaerobic conversion stage, the concentration of glucose and pH are controlled to obtain the product 1, 5-pentanediamine. The method is simple and easy to implement, and saves cost.
Description
Technical Field
The invention relates to the field of fermentation and biological catalysis of 1, 5-pentamethylene diamine, in particular to a method for producing 1, 5-pentamethylene diamine by combined culture of microorganisms.
Background
1,5-pentanediamine (1, 5-pentanediamine), also known as Cadaverine (cadeverine), 1, 5-diaminopentane, pentamethylenediamine or Cadaverine, is one of biogenic amines (including putrescine, spermine, spermidine, Cadaverine and the like), is a nitrogenous base which is widely present in organisms and has biological activity, and is a product generated by lysine undergoing a decarboxylation reaction under the action of decarboxylase during protein putrefaction. Has wide application in agriculture, medicine and industry. In agriculture, the 1,5-pentanediamine can be used for regulating and controlling the plant aging process, promoting the development of male and female stamens, improving the development of plant fruits and increasing the fruit yield; medically, the composition can also be used as a medicine component for effectively treating dysentery; the polyamide is an extremely important chemical raw material in industry, and can be polymerized with dibasic acids such as adipic acid, succinic acid, sebacic acid and the like to form novel materials of polyamide 5.6, polyamide 5.4 and polyamide 5.10 respectively.
With rapid economic development, the trend of atmospheric pollution and global warming is increasingly worsened. A large amount of polyamide from petrochemical resources is consumed in the world every year, the pentamethylene diamine is used as an important component monomer of the polyamide, the biological synthesis of the pentamethylene diamine has economic and ecological significance, and genetically engineered bacteria for synthesizing the pentamethylene diamine by the biological method mainly comprise corynebacterium glutamicum and escherichia coli. Currently, there are two main ways for synthesizing 1,5-pentanediamine by biological methods: fermentation processes and biotransformation processes. The fermentation method has the advantages of wide and renewable raw material sources, low cost, high yield and less pollution, but the regulation and control process is complex; the biotransformation method has high yield, low cost and simple process, and is beneficial to downstream extraction operation. However, in order to realize industrial production, a large amount of bacteria needs to be obtained, which requires a proper culture medium and fermentation culture technology. The microorganism combined culture is to combine culture a succinic acid escherichia coli with high yield and taking glucose as a unique carbon source and an escherichia coli with high activity and lysine decarboxylase with glycerol as a unique carbon source, and organically combine fermentation and transformation. The method can directly obtain the butanedioic acid pentanediamine salt, and can be used for synthesizing polyamide 5.4.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a method for producing 1,5-pentanediamine by microorganism combined culture, which simplifies the production method and reduces the production cost.
A method for producing 1,5-pentanediamine by microorganism co-culture comprises the following steps:
step 1, preparing a seed culture medium, a fermentation culture medium, a glucose feeding culture solution, a glycerol feeding culture solution, a lactose inducing solution and a lysine solution for conversion;
step 2, sterilizing a fermentation tank, a fermentation medium, a seed culture medium, a glucose supplemented culture solution, a glycerol supplemented culture solution, a lactose inducing solution, a lysine solution and a triangular flask, wherein the glucose in the fermentation medium is independently sterilized and then is combined with other components;
step 3, taking two sterilized triangular flasks, inoculating the sterilized seed culture medium into the two sterilized triangular flasks, and respectively inoculating succinic acid-producing bacteria and lysine-producing decarboxylase bacteria to the triangular flasks to perform shake culture to obtain fermentation strains;
step 4, inoculating the sterilized fermentation medium into a fermentation tank, and introducing sterile air or pure O2Then inoculating fermentation strains into the fermentation tank according to the inoculation amount of which the total volume ratio is 10 percent, adding glucose supplemented culture solution, glycerol supplemented culture solution and lactose induced solution into the fermentation tank, and controlling the specific growth rate, temperature, pH and dissolved oxygen of the thalli in the fermentation process;
step 5, when the dry weight of the thallus reaches 15-20g/L, stopping introducing sterile air or pure O2And transferring to an anaerobic conversion process, wherein a glucose supplemented culture solution is added in the anaerobic conversion process to control the glucose concentration to be between 1 and 4g/L, a lysine solution is used to control the pH to be between 6.5 and 7.5, and the product 1,5-pentanediamine is obtained after fermentation for 24 hours.
Preferably, the total carbon concentration of glucose and glycerol in the fermentation medium in step 1 is 25-50 g/L.
Preferably, the inoculation volume ratio of the succinic acid-producing bacteria to the lysine-producing decarboxylase bacteria in the fermentation strains is 15: (1-3).
Preferably, sterile air or pure O is introduced in step 42The amount of the culture medium is 0.03-0.08L/(min. L), and the glucose feed culture medium and the glycerol feed culture medium are supplemented according to a set specific growth rate of 0.04-0.08h-1Performing exponential feeding, wherein the acceleration rate of lactose-induced culture fluid flow is 20-50 mL/h.
Preferably, in the step 4, the temperature is controlled to be 32-37 ℃, the pH is controlled to be 6.5-7.5, and the dissolved oxygen is controlled to be 25-35%.
Preferably, the pH in step 4 is adjusted by 50% by volume of aqueous ammonia.
Preferably, the glucose concentration in step 5 is controlled to be 1-4 g/L.
Advantageous effects
The method of the invention simplifies the production method of the 1,5-pentanediamine, and compared with whole cell transformation, the method not only omits the step of collecting thalli, but also effectively omits the addition of acid in the transformation process. The carbon dioxide generated in the conversion process is fully utilized, so that the production cost is greatly saved.
Drawings
FIG. 1 shows the results of MS analysis of a co-cultured product of a microorganism of the present invention, wherein Peak 1 is monodisamidocadaverine;
FIG. 2 shows the result of MS analysis of the product of the microbial co-culture, wherein peak 2 is cadaverine dicadanide.
Detailed Description
Example 1
A method for producing 1,5-pentanediamine by microorganism co-culture comprises the following steps:
step 1, preparing a seed culture medium, a fermentation culture medium, a glucose feeding culture solution, a glycerol feeding culture solution, a lactose inducing solution and a lysine solution, wherein the formula is as follows:
seed culture medium: peptone 1%, yeast powder 0.5%, NaCl 0.8%, ampicillin 0.01%, chloramphenicol 0.01%, pH7.0.
Fermentation medium (g/L): 3.0g of citric acid, 3.0g of Na2HPO4·7H2O, 8.00 g KH2PO4,0.20 g NH4Cl, 0.75 g (NH4)2SO4, 0.84 g NaHCO3, 1.00gMgSO4·
7H2O, 10.0 mg CaCl2·2H2O,0.28mg FeSO4·7H20, 20mg/L thiamine (filter sterilization), 2mg/L biotin (filter sterilization), 0.1 percent of mixed trace element liquid, 30g/L glucose (sub sterilization), 2g/L glycerol (sub sterilization), 0.01 percent of ampicillin and 0.01 percent of chloramphenicol.
Mixed solution of trace elements (1)M):(NH4)6Mo7O24 3x10-9 M,H3BO3 4x10-7 M,CoCl2·6H20 3x10-8 M,CuSO4·5H2O 1x10-8 M,MnCl2·4H20 8x10-8 M,ZnSO4·7H2O 1x10-8 M。
Glucose supplemented culture solution: 600g/L glucose solution, and sterilizing at 115 deg.C for 10 min.
Glycerol supplemented culture solution: 230g/L glycerol solution. The sterilization condition is 115 deg.C, 10 min.
Lactose induction culture solution: 120g/L lactose solution. The sterilization condition is 115 deg.C, 10 min.
Lysine solution: 400g/L lysine solution.
Step 2, sterilizing a fermentation tank, a fermentation culture medium, a seed culture medium, a glucose feeding culture medium, a glycerol feeding culture medium, a lactose induction culture medium, a lysine solution and a 500ml triangular flask at 121 ℃ for 15min for later use, wherein the glucose in the fermentation culture medium is independently sterilized and then is combined with other components;
step 3, taking the sterilized Erlenmeyer flask, inoculating 50ml of seed culture medium, respectively inoculating succinic acid-producing bacteria and lysine decarboxylase-producing strains, and culturing for 8 hours at the rotating speed of 200rpm at 37 ℃ of a shaking table;
step 4, inoculating the fermentation medium into a sterilized fermentation tank, introducing sterile air, wherein the ventilation rate is 0.07L/(min.L), inoculating fermentation strains into the fermentation tank according to the volume ratio of the inoculation amount to the fermentation medium being 10%, wherein the ratio of the succinic acid-producing strains to the lysine decarboxylase-producing strains is 15:1, allowing the strains to grow and consume the fermentation medium in the fermentation tank, supplementing a glucose feed supplement culture solution and a glycerol feed supplement culture solution according to the ratio of glucose to glycerol in the fermentation medium after the initial carbon source in the culture medium is consumed, and controlling the specific growth rate of the strains to be 0.07h in the process-1Simultaneously adding lactose to induce the culture solution at the speed of 30 ml/h;
step 5, stopping the air supply when the dry weight of the bacteria reaches 15g/L, and stopping the air supply when the dry weight of the bacteria reaches 15g/LThe pH value in the primary fermentation process is controlled to be 6.8, and the temperature is controlled to be 37 ℃. After stopping introducing air, introducing CO2And simultaneously stopping feeding the glycerol feeding culture solution and the lactose inducing culture solution, continuously feeding the glucose feeding culture solution, controlling the sugar concentration to be between 1 and 2g/L in the process, using a lysine solution to replace ammonia water to control the pH to be 6.8, controlling the temperature to be 37 ℃, and measuring the yield of the pentanediamine after 24 hours.
The 1,5-pentanediamine content was derivatized with dansyl chloride and analyzed by HPLC-MS. The derivatization steps are as follows: 100 ul of the centrifuged transformation solution was transferred to a 5ml centrifuge tube, and 200. mu.l of 2M NaOH solution, 300. mu.l of saturated NaHCO3 solution, 100. mu.l of 10 g/1, 7-diaminoheptane solution (internal standard) and 1 ml of 10 g/l dansyl chloride solution were sequentially added. Mixing, placing in 40 deg.C water bath, reacting in dark for 45 min, adding 25% ammonia water 100 μ l, mixing, standing in dark at room temperature for 30 min. After the reaction was completed, the volume was adjusted to 5ml with acetonitrile.
HPLC-MS analysis used electrospray ion mass spectrometry and the column was a Prevail C18 reverse phase column (250 mm. times.4.6 mm. times.5 μm). The HPLC conditions were as follows: mobile phase A: 100% acetonitrile, mobile phase B: 0.1M ammonium acetate solution, using gradient elution, conditions were as follows: initially: 50% of A; 19 min: 90% of A; 20-30 min: 50% of A; flow rate: 1.0 ml/min; column temperature: 40 +/-1 ℃; sample introduction amount: 10 μ l. The detection uses an ultraviolet detector, and the detection wavelength is 254 nm.
The converted product was analyzed by HPLC-MS (as shown in FIG. 1, FIG. 2) and showed a peak 1 molecular weight of 335 (336-1 = 335) and a peak 2 molecular weight of 568 (569-1 = 568), which were matched to the molecular weights of monodisamide and dicambamide, respectively.
Example 2
Steps 1 to 3 are the same as in example 1.
Step 4, inoculating the fermentation medium into a sterilized fermentation tank, adding glucose and glycerol solution according to the ratio of 15:1, introducing sterile air, wherein the ventilation rate is 0.07L/(min. L), inoculating fermentation strains into the fermentation tank according to the volume ratio of the inoculation amount to the fermentation medium of 10%, wherein the ratio of the succinic acid-producing strain to the lysine decarboxylase-producing strain is 15:1, allowing the bacteria to grow and consume the fermentation medium in the fermentation tank, and waiting to cultureAfter the initial carbon source in the medium is consumed, supplementing a glucose supplementing culture solution and a glycerol supplementing culture solution according to the ratio of glucose to glycerol in the fermentation culture medium, and controlling the specific growth rate of thalli to be 0.07h in the process-1Simultaneously adding lactose to induce the culture solution at the speed of 30 ml/h;
and 5, stopping introducing air when the dry weight of the thalli reaches 15g/L, and controlling the pH value to be 6.8 and the temperature to be 37 ℃ in the fermentation process before the air introduction. After stopping aeration, CO is not introduced in the step2CO fixed for succinic acid production2Supplying by lysine decarboxylation, stopping feeding glycerol feeding culture solution and lactose inducing culture solution, and feeding glucose feeding culture solution continuously, wherein the sugar concentration is controlled to be between 1 and 2g/L, and lysine solution is used for replacing ammonia water to control the pH to be 6.8 and the temperature to be 37 ℃. The pentanediamine yield was determined after 24 hours. The measurement method was the same as in example 1.
Example 3
Steps 1-3 the same as in example 1, wherein the glucose concentration in the fermentation medium was 25g/L and the glycerol concentration was 5 g/L.
Step 4, inoculating the fermentation medium into a sterilized fermentation tank, adding a glucose and glycerol solution according to the ratio of 5:1, introducing sterile air, wherein the ventilation rate is 0.07L/(min.L), inoculating fermentation strains into the fermentation tank according to the volume ratio of the inoculum size to the fermentation medium of 10%, wherein the ratio of the succinic acid-producing strain to the lysine decarboxylase-producing strain is 5:1, allowing the bacteria to grow and consume the fermentation medium in the fermentation tank, supplementing a glucose feed supplement culture solution and a glycerol feed supplement culture solution according to the ratio of the glucose to the glycerol in the fermentation medium after the initial carbon source in the culture medium is consumed, and controlling the specific growth rate of the bacteria to be 0.07h in the process-1Simultaneously adding lactose induction culture solution at the speed of 25 ml/h;
and 5, stopping introducing air when the dry weight of the thalli reaches 20g/L, and controlling the pH value to be 6.8 and the temperature to be 37 ℃ in the fermentation process before the air introduction. After stopping introducing air, introducing CO2Stopping feeding glycerol and lactose induced culture solution, continuously feeding glucose, controlling sugar concentration at 1-2g/L, and adding lysineThe pH was controlled to 6.8 and the temperature was controlled to 37 ℃ by using an acid solution instead of ammonia water. The pentanediamine yield was determined after 24 hours. The measurement method was the same as in example 1.
Comparative example
The lysine decarboxylase producing strain is used for fermentation, substrate lysine is added at the later stage, pH regulation is carried out by succinic acid, other reaction conditions are the same as those in example 1, and the maximum concentration of the pentanediamine in fermentation liquor after the fermentation is finished reaches 50.62 g/L.
The yield of 1,5-pentanediamine produced by the process of the present invention is reported in the table below.
The data show that the invention has large yield of 1,5-pentanediamine and simple preparation process, and is suitable for industrialization.
Claims (7)
1. A method for producing 1,5-pentanediamine by microorganism co-culture is characterized by comprising the following steps:
step 1, preparing a seed culture medium, a fermentation culture medium, a glucose feeding culture solution, a glycerol feeding culture solution, a lactose inducing solution and a lysine solution;
step 2, sterilizing a fermentation tank, a fermentation medium, a seed culture medium, a glucose supplemented culture solution, a glycerol supplemented culture solution, a lactose inducing solution, a lysine solution and a triangular flask, wherein the glucose in the fermentation medium is independently sterilized and then is combined with other components;
step 3, taking two sterilized triangular flasks, inoculating the sterilized seed culture medium into the two sterilized triangular flasks, and respectively inoculating succinic acid-producing bacteria and lysine-producing decarboxylase bacteria to the triangular flasks to perform shake culture to obtain fermentation strains;
step 4, inoculating the sterilized fermentation medium into a fermentation tank, and introducing sterile air or pure O2Inoculating fermentation strain into the fermentation tank according to the inoculation amount of 10% of the total volume ratio, adding glucose supplemented culture solution, glycerol supplemented culture solution and lactose inducing solution into the fermentation tank, and controlling the growth rate, temperature, pH and dissolved oxygen of thallus ratio during fermentation;
Step 5, when the dry weight of the thallus reaches 15-20g/L, stopping introducing sterile air or pure O2Transferring to an anaerobic conversion process, adding glucose supplemented culture fluid to control the glucose concentration, controlling the pH with lysine solution, and fermenting for 24 hours to obtain a product 1, 5-pentanediamine;
fermentation medium (g/L): 3.0g citric acid, 3.0g Na2HPO4·7H2O,8.00g KH2PO4,0.20g NH4Cl,0.75g(NH4)2SO4,0.84g NaHCO3,1.00gMgSO4·7H2O,10.0mg CaCl2·2H2O,0.28mg FeSO4·7H20, 20mg/L thiamine, 2mg/L biotin, 0.1 percent of mixed trace element liquid, 30g/L glucose, 2g/L glycerol, 0.01 percent of ampicillin and 0.01 percent of chloramphenicol.
2. The method for producing 1,5-pentanediamine by the combined culture of the microorganisms according to claim 1, wherein: the total carbon concentration of glucose and glycerol in the fermentation medium in the step 1 is 25-50 g/L.
3. The method for producing 1,5-pentanediamine by the combined culture of the microorganisms according to claim 1, wherein: in the step 4, the inoculation volume ratio of the succinic acid-producing bacteria to the lysine-producing decarboxylase bacteria in the fermentation strains is 15: (1-3).
4. The method for producing 1,5-pentanediamine by the combined culture of the microorganisms according to claim 1, wherein: in step 4, sterile air or pure O is introduced2The amount of the culture medium is 0.03-0.08L/(min. L), and the glucose feed culture medium and the glycerol feed culture medium are supplemented according to a set specific growth rate of 0.04-0.08h-1Performing exponential feeding, wherein the acceleration rate of lactose-induced culture fluid flow is 20-50 mL/h.
5. The method for producing 1,5-pentanediamine by the combined culture of the microorganisms according to claim 1, wherein: in step 4, the temperature is controlled at 32-37 ℃, the pH is controlled at 6.5-7.5, and the dissolved oxygen is controlled at 25-35%.
6. The method for producing 1,5-pentanediamine by the combined culture of the microorganisms according to claim 1, wherein: the pH during the fermentation in step 4 is adjusted by 50% by volume of ammonia.
7. The method for producing 1,5-pentanediamine by the combined culture of the microorganisms according to claim 1, wherein: in step 5, the glucose concentration is controlled to be 1-4 g/L.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610609543.2A CN106011216B (en) | 2016-07-28 | 2016-07-28 | Method for producing 1,5-pentanediamine by microorganism combined culture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610609543.2A CN106011216B (en) | 2016-07-28 | 2016-07-28 | Method for producing 1,5-pentanediamine by microorganism combined culture |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106011216A CN106011216A (en) | 2016-10-12 |
CN106011216B true CN106011216B (en) | 2019-12-27 |
Family
ID=57114987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610609543.2A Active CN106011216B (en) | 2016-07-28 | 2016-07-28 | Method for producing 1,5-pentanediamine by microorganism combined culture |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106011216B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108531494B (en) * | 2018-03-09 | 2020-11-10 | 南京工业大学 | Method for preparing bio-based nylon-54 precursor by co-fermentation of genetically engineered bacteria |
CN110468167B (en) * | 2018-05-04 | 2022-12-27 | 上海凯赛生物技术股份有限公司 | Method for producing 1, 5-pentanediamine by fermentation |
CN110541010A (en) * | 2018-05-29 | 2019-12-06 | 上海凯赛生物技术股份有限公司 | Preparation method and culture medium of dibasic acid pentanediamine salt |
CN110541009A (en) * | 2018-05-29 | 2019-12-06 | 上海凯赛生物技术股份有限公司 | fermentation liquor containing dibasic acid pentanediamine salt, method and prepared dibasic acid pentanediamine |
FR3087779B1 (en) * | 2018-10-26 | 2021-10-08 | Arkema France | BIOSOURCED DIAMINE BASED RHEOLOGY ADDITIVE |
CN112322672A (en) * | 2020-11-16 | 2021-02-05 | 中海油常州涂料化工研究院有限公司 | Method for preparing pentanediamine through multi-bacterium combined fermentation |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104152497A (en) * | 2014-09-11 | 2014-11-19 | 南京工业大学 | Method for producing succinic acid by multistage continuous fermentation |
CN104762336A (en) * | 2014-01-06 | 2015-07-08 | 上海凯赛生物技术研发中心有限公司 | Method for preparing 1,5-pentanediamine |
CN105316270A (en) * | 2014-06-27 | 2016-02-10 | 中国科学院微生物研究所 | Engineering bacteria for catalytically producing 1,5-pentanediamine and application thereof |
-
2016
- 2016-07-28 CN CN201610609543.2A patent/CN106011216B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104762336A (en) * | 2014-01-06 | 2015-07-08 | 上海凯赛生物技术研发中心有限公司 | Method for preparing 1,5-pentanediamine |
CN105316270A (en) * | 2014-06-27 | 2016-02-10 | 中国科学院微生物研究所 | Engineering bacteria for catalytically producing 1,5-pentanediamine and application thereof |
CN104152497A (en) * | 2014-09-11 | 2014-11-19 | 南京工业大学 | Method for producing succinic acid by multistage continuous fermentation |
Non-Patent Citations (2)
Title |
---|
《Coproduction of succinic acid and cadaverine》;Jing Wang等;《Green Chemistry》;20180516;第20卷;第2880–2887页 * |
《用固定化L-赖氨酸脱羧酶细胞制备1,5-戊二胺》;蒋丽丽;《精细化工》;20071130;第24卷(第11期);第1080-1084页 * |
Also Published As
Publication number | Publication date |
---|---|
CN106011216A (en) | 2016-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106011216B (en) | Method for producing 1,5-pentanediamine by microorganism combined culture | |
CN112251475B (en) | Method for improving L-glutamine fermentation yield and sugar-acid conversion rate | |
CN103224965A (en) | Method for producing pyrroloquinoline quinine through microbial fermentation and fermentation medium used in same | |
CN110218661A (en) | A kind of Candida tropicalis and its application and a kind of production method of long-chain biatomic acid | |
CN107267422B (en) | Comamonas testosteroni HHALA-001 and method for producing L-alanine by using same | |
CN106929548A (en) | The technique that malic acid is produced in a kind of use aspergillus oryzae fermentation | |
CN106834377A (en) | A kind of method for producing epothilone B | |
CN106591401B (en) | Fermentation promoter for increasing yield of gentamicin C1a and addition method thereof | |
CN114921502B (en) | Glutaric acid production method for feedback regulation and control of nitrogen source flow based on microorganism physiological parameters | |
TWI627278B (en) | Mutant of corynebacterium glutamicum producing l-histidine and method for producing l-histidine using the same | |
CN107217007B (en) | Fermentation medium for producing PF1022A and fermentation method | |
CN104830923B (en) | A kind of method for producing L-Glutamine from Pidolidone biotransformation method using lactobacillus thermophilus | |
JP3074781B2 (en) | Production method of L-lysine by fermentation method | |
CN102747114A (en) | Method for regulating recombinant escherichia coli metabolism by using transient anaerobic fermentation | |
CN102321683B (en) | Process for preparing fumaric acid fermentation liquid by fermentation method and for separating and extracting pure fumaric acid from fumaric acid fermentation liquid | |
CN105695520B (en) | Method for increasing yield of 2-keto-D-gluconic acid produced by fermentation method | |
CN117625706A (en) | Method for improving fermentation yield of L-proline | |
CN104404095B (en) | A kind of method of fermenting and producing L-Leu | |
CN104531506A (en) | Fiber bed reactor suitable for aerobic fermentation and method for producing L-ornithine by using fiber bed reactor | |
CN106755142B (en) | Method for preparing L-lactic acid by rhizopus oryzae thallus whole cell catalysis | |
CN104498542A (en) | Method for preparing L-lactic acid employing continuous method in fermentation manner | |
CN116590203B (en) | Corynebacterium glutamicum and application thereof in fermentation production of L-isoleucine | |
JP2006521801A (en) | Fermentation method using low concentration carbon-containing nutrients and nitrogen-containing nutrients | |
CN113122591A (en) | Method for producing staurosporine by fermentation | |
CN116445562A (en) | Strain culture method for high-yield PQQ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |